Practically Speaking: Adjuvant Therapy for Kidney Cancer

To be added to the distribution list email: DDeCastro@southlakeregional.org

In this episode, Dr. Lalani will discuss the recent advances in the perioperative management of renal cancer.  He will discuss the practical aspect of incorporating this into daily practice. 

Key Opinion Leader: 
Dr. Aly-Khan Lalani 
Assistant Professor of Medicine
Staff Medical Oncologist
Juravinski Cancer Centre
McMaster University

Host:
Dr. Shaqil Kassam 
skassam@southlakeregional.org 
Medical Oncologist 
Stronach Regional Cancer Centre, Newmarket, Ontario 

Outline:
0:00 - Introduction
2:00 - Cross trial comparisons
5:40 - Adjuvant pembrolizumab - Standard of Care?
8:30 - VEGF TKIs in the Adjuvant Setting
9:30 - Do we need to wait for OS?
12:10 - Subgroups?
19:00 - Practical aspects of use.
24:20 - CPS
26:00 - q6 weekly dosing
27:35 - Subsequent lines of treatment. 

Previous Episodes: 
Gastric Cancer: http://tobtr.com/12051154
NGS: http://tobtr.com/12072620
Paxlovid and Cancer treatment:http://tobtr.com/12090165
Billiary Tract Cancers: http://tobtr.com/12135321